Physician profile
Peter Yeh
NPI 1073977914
$3,060.62
in general payments reported to CMS, 2019-2025
11 companies · $966 in 2025
The $966 reported for 2025 was more than what 87% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.84 · 2021: $274 · 2022: $1,216 · 2023: $325 · 2024: $266 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,783.40 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $658.31 | 2025 | Senza |
| Baxter Healthcare | $130.80 | 2024 | Tisseel |
| Relievant Medsystems, INC. | $123.68 | 2022 | |
| Nevro Corp. | $97.36 | 2023-2024 | Senza |
| Spr Therapeutics, INC | $93.00 | 2025 | Sprint Pns System |
| Boston Scientific Corporation | $65.56 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $64.85 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $16.00 | 2025 | Euflexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.84 | 2020 | |
| Averitas Pharma INC. | $13.82 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.